Clinical Trials Logo
  1. Home
  2. Dry Eye
  3. NCT04960696
  4. Details
NCT04960696 Clinical Trial

Effect on Ocular Surface Symptoms of Online Education

Dry Eye Clinical Trial

Official title:
An Evaluation of the Effect on Ocular Surface Symptoms of Online Education During the Pandemic

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04960696
Other study ID # desicion:06, dated: 12/04/21
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 14, 2021
Est. completion date June 20, 2021

Study information
Verified date July 2021
Source Kahramanmaras Sutcu Imam University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

retrospective, observational study.

Description:

Aim: The aim of this study was to investigate the effects on ocular surface symptoms of students taking online education, which was a part of the distance learning model during the COVID-19 pandemic, to be able to prevent the formation of irreversible damage with early diagnosis and treatment. With recommendations that can be simply applied, it was aimed to protect ocular health. Material and Method: The study included 315 students who were undertaking online education and presented at the Ophthalmology Department of a tertiary level university hospital. A record was made of sociodemographic data, Schirmer test results, tear break-up time (TBUT) measurements, and Ocular Surface Disease Index (OSDI) scores. The data were analyzed statistically using SPSS vn. 22.0 software, and a value of p<0.05 was accepted as statistically significant.

Recruitment information / eligibility
Status Completed
Enrollment 315
Est. completion date June 20, 2021
Est. primary completion date June 15, 2021
Accepts healthy volunteers
Gender All
Age group 6 Years to 30 Years
Eligibility Inclusion Criteria: Online education >6 years <30 years student Exclusion Criteria: not student not taking online education <6 years >30 years

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• OSDI
Change of OSDI in distance education
• tear break up time
Change of tear break up time in distance education
• schirmer
Change of schirmer in distance education

Locations
Country Name City State
Turkey Abdullah Beyoglu Kahramanmaras In The USA Or Canada, Please Select...

Sponsors (1)
Lead Sponsor Collaborator
Kahramanmaras Sutcu Imam University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Dry eye symptom scale: ocular symptom scale index (OSDI) Change of OSDI in distance education baseline
Primary Dry eye symptom scale:Tear break up time (TBUT) Change of tear break up time in distance education baseline
Primary Dry eye scale:Schirmer Change of Schirmer in distance education baseline
See also
  Status Clinical Trial Phase
Completed NCT05027087 - The Effect of a Novel Blueberry Supplement on Dry Eye Disease Phase 3
Completed NCT05102409 - An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease Phase 2
Completed NCT06159569 - Performance and Tolerability of the Medical Device LACRIACT N/A
Completed NCT04081610 - Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution Phase 1
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05825599 - PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms N/A
Completed NCT03418727 - Dry Eye Disease Study With Brimonidine Phase 2
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Recruiting NCT04527887 - Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED) Phase 4
Not yet recruiting NCT06379685 - Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. Phase 1
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Completed NCT04553432 - Dry Eye OmniLenz Application of Omnigen Research Study Phase 4
Recruiting NCT04109170 - Dry Eye Evaluation System Based on Bioinformatics
Completed NCT04105842 - Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type N/A
Completed NCT05505292 - Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers Phase 4
Completed NCT04668131 - Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease N/A
Completed NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Phase 4
Completed NCT02235259 - Efficacy and Safety of XG-104 for the Treatment of Dry Eye Phase 2
Not yet recruiting NCT02218827 - Topical Steroid Treatment For Dry Eye N/A
Completed NCT01959854 - Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye N/A